Robert Blum | BiotechTV

top of page

Cytokinetics’ CEO Robert Blum discusses today’s SEQUOIA-HCM P3 result

Dec 27, 2023

Company News

Cytokinetics’ CEO Robert Blum discusses today’s SEQUOIA-HCM P3 result

Robert Blum describes Aficamten’s topline safety, efficacy, and how the company views its competitive profile.

Checking in with Cytokinetics ahead of the SEQUOIA-HCM P3 study result due in December

Nov 20, 2023

Company News

Checking in with Cytokinetics ahead of the SEQUOIA-HCM P3 study result due in December

President and CEO Robert Blum describes aficamten's mechanism, the trial's study design, and reflects on Cytokinetics' 25 years.

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Klein Hersh is a precision executive search firm with over 25 years of proven success partnering with clients to deliver the visionary leaders shaping the future of life sciences and healthcare. We believe that the innovation behind a healthier world starts with bringing the best and brightest minds together. Our experienced team of dedicated experts is deeply immersed in every facet of pharma, biotech, and healthcare, and has developed trusted relationships with far-reaching talent networks.

Visit Klein Hersh